In a surprising announcement last week, the United States (US) reversed course on its position towards the COVID-10 TRIPS Agreement waiver negotiations, saying it would negotiate a waiver at the World Trade Organization (WTO). US Republican lawmakers and the pharmaceutical industry pushed back on the decision, warning it would allow the People’s Republic of China … Continue Reading
